一家投资研究公司想证明人工智能能够彻底改变药物研发。于是他们与Anthropic合作，测试一个未发布的Claude版本能否制造蝎子抗毒血清。结果它做不到。专家告诉，它提出了一些有希望的起点，但远未达到实际药物的程度。
An investment research firm wanted to prove AI could revolutionize drug development. So they teamed up with Anthropic to see whether an unreleased version of Claude could make scorpion antivenom. It couldn't. It came up with some promising starting points, but nothing close to an actual drug, experts tell .
进行这项实验的公司Citrini Research承认，“我们中没有人能声称自己了解人工智能与生物学相关的任何知识。”但这并没有阻止它尝试从头制造一种药物——也没有阻止它发布一篇题为《我们想用Claude创造一种新药。以下是发生的事情》的博客文章。该叙述完全……
Citrini Research, the firm behind the experiment, admitted that "none of us could claim to know anything about AI as it related to biology." That didn't stop it from trying to make a drug from scratch - or publishing a blog post titled "We Wanted to Use Claude to Create a New Drug. Here's What Happened." The account came comple …